NAVER D2SF Strengthens Investment in Nuvilab, Pioneering AI Nutrition Analytics #South_Korea #Seongnam #NAVER_D2SF #AI_Nutrition #Nuvilab
NEOWIZ Kicks Off Exciting Steam Sale with Four Popular Titles #South_Korea #Seongnam #SANABI #Skul #DJMAX_RESPECT_V
NCSOFT Unveils Ambitious Growth Strategy and Revenue Target for 2030 #South_Korea #Seongnam #Mobile_Gaming #Growth_Strategy #NCSOFT
NAVER D2SF Makes Strategic Investment in Khameleon for AI-driven Hotel Automation #South_Korea #Seongnam #NAVER_D2SF #Khameleon #Donghoon_Lee
Doosan Robotics Partners with Kwangjin Group for Innovative Manufacturing Solutions #South_Korea #Seongnam #Manufacturing_Robots #Doosan_Robotics #Kwangjin_Group
NAVER D2SF Makes Strategic Investment in Sorcerics to Advance Ambient AI Home Solutions #South_Korea #Seongnam #Ambient_AI #NAVER_D2SF #Sorcerics
SN BioScience's Innovative SNB-101 Receives FDA's Orphan Drug Designation for Gastric Cancer Treatment #South_Korea #Seongnam #SN_BioScience #Orphan_Drug #Nano_Drug
#Boeing #787-8 Dreamliner, #Boeing Company (N787BA) by Yunjin Lee (#Seongnam AB) #Airliners #aviation #photography #avgeeks
LIMIT ZERO BREAKERS: A Dive into the Exciting Anime RPG Experience #South_Korea #Seongnam #MAPPA #NCSOFT #LIMIT_ZERO
Cats & Soup Unveils Festive Christmas Updates and Special Events This December #South_Korea #Seongnam #Neowiz #Cats_&_Soup #Christmas_Update
L&C Bio's Re2O Leads K-Medical Tourism in Just One Year #South_Korea #Seongnam #LC_Bio #Re2O #K-Medical
Tiumbio Showcases Promising Clinical Results for Novel Cancer Drug at SITC 2025 #South_Korea #Seongnam #TiumBio #Tosposertib #SITC2025
Utility Partners with Seongnam City for H2Gen Hydrogen Project in Korea #South_Korea #Seongnam #Seongnam_City #H2Gen #Utility_Global
SK bioscience Advances Towards First-in-Human Trial for Universal Coronavirus Vaccine in Australia #Australia #Seongnam #COVID-19_vaccine #SK_bioscience #Universal_Vaccine
NEXT Market Achieves $15 Million in Transactions Within a Month of Launch #South_Korea #Seongnam #LINE_NEXT #LORDNINE #NEXT_Market
LIMIT ZERO BREAKERS Unveils Stunning New PV and Exciting Campaign! #South_Korea #Seongnam #MAPPA #NCSOFT #LIMIT_ZERO_BREAKERS
NAVER D2SF enhances its investment portfolio with GravityLabs' innovative health solutions #South_Korea #Seongnam #NAVER_D2SF #GravityLabs #MoneyWalk
Lineage2M Unveils New Class Skins and Features in Latest Update #Japan #Seongnam #NCSOFT #Lineage2M #Master_Alchemy
NAVER CEO Choi Soo-yeon Joins UN Global Compact Board to Shape AI Governance Worldwide #South_Korea #AI_Governance #Seongnam #Naver #Choi_Soo-yeon
NAVER D2SF's Strategic Investment in Voice AI Startup Podonos Enhances AI Model Evaluation #South_Korea #Seongnam #Voice_AI #NAVER_D2SF #Podonos
SK bioscience Takes Major Step Forward with IND Submission for 2-Dose Varicella Vaccine Phase 3 Trial #South_Korea #Seongnam #SK_bioscience #Varicella_Vaccine #SKYVaricella
PharmaResearch Partners with VIVACY for Rejuran Distribution in Europe #South_Korea #Seongnam #Rejuran #PharmaResearch #VIVACY
PharmaResearch and VIVACY Forge Strategic Partnership for Rejuran Distribution in Europe #South_Korea #Seongnam #Rejuran #PharmaResearch #VIVACY
PharmaResearch Partners with VIVACY to Launch 'Rejuran' Across Europe #South_Korea #Seongnam #Rejuran #PharmaResearch #VIVACY
PharmaResearch Unveils Strategic Partnership for Rejuran's European Distribution in 22 Nations #South_Korea #Seongnam #Rejuran #PharmaResearch #VIVACY
NEOWIZ Launches Global Fan Art Contest for Brown Dust 2 with $25,000 Prize Pool #South_Korea #Seongnam #Neowiz #Contest #Brown_Dust_2
Doosan Robotics Accelerates Its Move to Lead The AI Robotics Market #South_Korea #AI_Technology #Seongnam #Doosan_Robotics #ONExia
Doosan Robotics Intense Focus on Becoming a Global AI Robot Solutions Leader #USA #AI_Solutions #Seongnam #Doosan_Robotics #ONExia
Doosan Robotics Aims to Lead in AI Robotics with Global Expansion and Innovation Strategy #South_Korea #AI_Solutions #Seongnam #Doosan_Robotics #ONExia
SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission #South_Korea #Seongnam #Influenza_vaccine #SK_bioscience #adjuvant_technology